83167-59-3

Usage

Uses

Used in Pharmaceutical Industry:
1-Propanol, 2-methoxy-3-(octadecyloxy)-, (2S)is used as a solvent for the production of pharmaceuticals due to its ability to dissolve a wide range of substances.
Used in Cosmetics Industry:
1-Propanol, 2-methoxy-3-(octadecyloxy)-, (2S)is used as a solvent in the production of cosmetics, contributing to the formulation and stability of various cosmetic products.
Used in Organic Synthesis:
1-Propanol, 2-methoxy-3-(octadecyloxy)-, (2S)is used as a reagent in organic synthesis, playing a role in the synthesis of complex organic molecules.
Used in Chemical Reactions:
1-Propanol, 2-methoxy-3-(octadecyloxy)-, (2S)is used as a reagent in various chemical reactions, facilitating the formation of desired products and improving reaction efficiency.

Upstream product

• 150844-22-7 1,6-di-O-octadecyl-2,5-di-O-methyl-3,4-bis-O-(4-methoxybenzyl)-D-mannitol 
• 10567-22-3 (R)-octadecylglycerol 
• 6076-32-0 3-O-Octadecyl-1-O-trityl-sn-glycerin 
• 83526-57-2 (S)-1-(benzyloxy)-3-(octadecyloxy)propan-2-ol 
• 80707-96-6 Ro 15-4454 
• 90126-20-8 1,6-di-O-octadecyl-2,5-di-O-methyl-D-mannitol 
• 866784-45-4 (R)-1-((tert-butyldimethylsilyl)oxy)-3-(octadecyloxy)propan-2-ol 
• 80707-93-3 (S)-1-O-octadecyl-2-O-benzyl-glycerol 
• 1348886-83-8 C₂₉H₅₂O₄ 
• 10585-86-1 1,2-Di-O-isopropyliden-3-O-octadecyl-sn-glycerin 
• 83526-60-7 2-O-Acetyl-1-O-benzyl-3-O-octadecyl-sn-glycerin 
• 83526-52-7 3-O-Octadecyl-2-O-p-toluolsulfonyl-sn-glycerin 
• 83526-54-9 3-O-Octadecyl-1-O-p-toluolsulfonyl-sn-glycerin 
• 83537-01-3 (-)-1-O-octadecyl-2-O-acetyl-sn-glycerol 

Downstream Products

• 65492-82-2 (+)-Edelfosine 
• 161454-34-8 2-O-methyl-1-O-octadecyl-sn-glycero-3-phoshphatidic acid diphenyl ester 
• 290812-53-2 1D-2,4,5,6-O-benzyl-3-deoxy-3-(benzyloxymethyl)-myo-inositol 2-[benzyl (R)-2-O-methyl-3-O-octadecylcarbonate] 
• 290812-52-1 1L-1,3,4,5-O-benzyl-6-deoxy-6-(benzyloxymethyl)-chiro-inositol 2-[benzyl (R)-2-O-methyl-3-O-octadecylcarbonate] 
• 335163-46-7 Diisopropyl-phosphoramidous acid benzyl ester (R)-2-methoxy-3-octadecyloxy-propyl ester 
• 701976-55-8 phosphoric acid 2-methoxy-3-octadecyloxy-propyl ester 2,3,4-trihydroxy-cyclohexyl ester 
• 701976-54-7 phosphoric acid 2-methoxy-3-octadecyloxy-propyl ester 2,3,4-trihydroxy-6-methoxy-cyclohexyl ester 
• 498555-01-4 Carbonic acid (R)-2-methoxy-3-octadecyloxy-propyl ester (1R,2R,3S,4R,6R)-2,3,4-tris-benzyloxy-6-methoxy-cyclohexyl ester 
• 498554-92-0 Phosphoric acid benzyl ester (R)-2-methoxy-3-octadecyloxy-propyl ester (1R,2R,3S,4R,6R)-2,3,4-tris-benzyloxy-6-methoxy-cyclohexyl ester 
• 498554-93-1 Phosphoric acid benzyl ester (R)-2-methoxy-3-octadecyloxy-propyl ester (1R,2R,3S,4R,6R)-2,3,4-tris-benzyloxy-6-isobutoxy-cyclohexyl ester 

Relevant academic research and scientific papers

ANTIVIRAL COMPOUNDS

The present disclosure provides compounds for treating a variety of diseases, such as respiratory syncytial virus (RSV), HRV, hMPV, ebola, Zika, West Nile, Dengue, and HCV.

Inhibitors of phosphatidyl myo-inositol cycle

The present invention relates to the preparation and biological activity of 3-deoxy-Dmyo-inositol ether lipid analogs as inhibitors of phosphatidylinositol-3-kinase signaling and cancer cell growth. The compounds of the present invention are useful as anti-tumor 5 agents which effectively inhibit the growth of mammalian cells.

D and L etherlipid stereoisomers and liposomes

A liposome having a lipid bilayer, where the lipid bilayer includes either the L or D stereoisomer of an ether lipid or a non-equal mixture of both. Most preferably the liposome also comprises (a) an underivatized phosphatidylcholine; (b) a sterol; (c) about 5-20 mole % of a phosphatidylethanolamine linked to a dicarboxylic acid at the ethanolamine group of the phosphatidylethanolamine, and (d) greater than about 10 mole % to less than about 30 mole % of either the L or D stereoisomer of an ether lipid. The liposome may be used as an anti-cancer or anti-inflammatory agent.

Synthesis of enantiomerically pure ether lipid analogues from D-mannitol

A new scheme for synthesis of enantiomerically pure ether lipid analogues 3-O-octadecyl-2-O-methyl-sn-glycero-phosphocholine (D-ET-18-OCH3), 1-O-octadecyl-2-O-methyl-sn-glycero-phosphocholine (L-ET-18-OCH3) and their oleyl analogues is described.The key s

Chiral PAF agonists: Synthesis, theoretical analysis of their stereoelectronic properties and structure activity relationships

A series of chiral PAF agonists were synthesized. Modifications at the PAF structure were undertaken as far as the C2 substituents and the onium head groups are concerned. In parallel, molecular modelling studies including a MOPAC geometry optimization and the analysis of the electrostatic potential were performed on the newly synthesized and on already known PAF agonists, in order to gain a better insight into the stereoelectronic features required for interaction with the PAF receptor.

D-mannite derivatives as starting products for the synthesis of phospholipids

The mannite derivatives have the formula (1) wherein R' and R2, idenal or different, represent when they are identical a straight or branched alkyl, alkenyl or alkynyl group containing from 5 to 24 atoms of carbon which may be substituted by a cycloalkyl residue having from 3 to 6 atoms of carbon, an aryl, benzyloxy, allyloxy, mesyloxy residue and/or halogen atoms and when R' and R2 are different, they represent a straight or branched alkyl group with 1 to 24 atoms or carbon, which may be substituted by a cycloalkyl residue having from 3 to 6 atoms of carbon, an aryl, benzyloxy, allyloxy, mesyloxy residue and/or halogen atoms, with the possibility for R' of being also a trityl group. From said mannite derivatives, it is possible to obtain in a simple way and with good yields the phospholipids in the form of their optical stereo isomers. STR1